Estimates compiled by Modular Finance on behalf of Ambea.
Number of contributors: 5 (all of which have been updated or confirmed before the report)
| Ambea, Group (MSEK, unless otherwise specified) | Q2 2026E |
| Net sales | 4,319 |
| Organic growth (%) | 3.62 |
| Adjusted EBITA | 344 |
| Profit before tax | 180 |
| Earnings per share (SEK) | 1.75 |
| Net sales per segment | |
| Nytida | 1,202 |
| Vardaga | 1,429 |
| Stendi | 862 |
| Validia | 442 |
| Altiden | 335 |
| Klara | 98.1 |
| Group adjustments | - 49.2 |
| Adjusted EBITA incl. IFRS 16 per segment | |
| Nytida | 139 |
| Vardaga | 123 |
| Stendi | 32.5 |
| Validia | 43.4 |
| Altiden | 6.64 |
| Klara | 8.72 |
| Unallocated items | - 8.94 |
More consensus estimates can be found on Ambea’s webpage: https://ambea.com/investor-relations/the-share/consensus/
Ambea’s Q2 report will be released on Wednesday 19 August at 7:00 CEST.